REGISTER
Total Artificial Lung System Sustains Survival for 48 Hours After Bilateral Pneumonectomy
A novel total artificial lung (TAL) system enabled a critically ill patient to survive for 48 hours without native lungs, stabilizing circulation and oxygenation until successful bilateral lung transplantation, according to a report published January 30 in Med, a journal of the Cell Press portfolio.

Surgeons at Northwestern Memorial Hospital in Chicago reported that a 33-year-old man remained hemodynamically stable for two days after complete surgical removal of both lungs, supported solely by an investigational TAL device. The patient subsequently underwent double lung transplantation and has maintained good graft function more than two years after discharge.

The case represents a rare clinical demonstration that long-term extracorporeal support can fully replace pulmonary gas exchange and vascular buffering in the absence of lungs—an outcome that could expand rescue options for select patients with end-stage lung failure and uncontrolled infection.

Clinical Context: ARDS Progression Despite Maximal Support

In spring 2023, the patient developed acute respiratory distress syndrome (ARDS) triggered by influenza infection, rapidly progressing to respiratory failure. After broad-spectrum antimicrobial therapy failed, he was transferred emergently to Northwestern Memorial Hospital and placed on extracorporeal membrane oxygenation (ECMO).

Despite ECMO and intensive care, the patient’s condition deteriorated. He developed necrotizing pneumonia, septic shock, and recurrent cardiac arrest episodes requiring cardiopulmonary resuscitation. Conventional ARDS therapies, including advanced life support, were unable to stabilize his cardiopulmonary physiology.

“His lung infection was extremely severe and had begun spreading systemically,” said Dr. Ankit Bharat, Chief of Thoracic Surgery at Northwestern University Feinberg School of Medicine and Executive Director of the Canning Thoracic Institute. “Compounding the problem, the causative pathogens were resistant to all available antibiotics.”

At that stage, the lungs had become a persistent source of inflammatory mediators. According to the treating team, bilateral pneumonectomy combined with pleural debridement represented the only potential life-saving intervention.

The Therapeutic Dilemma of Lung Removal Without Immediate Transplant

Removing both lungs creates an immediate loss of gas exchange and disrupts pulmonary vascular resistance, threatening catastrophic circulatory collapse. While modified ECMO configurations have previously been used in similar scenarios, outcomes have been inconsistent.

Bilateral pneumonectomy eliminates the pulmonary vascular bed, abruptly increasing venous return to the right ventricle while obstructing pulmonary artery outflow. In septic patients with unstable hemodynamics, ECMO systems—lacking intrinsic adaptability to rapid circulatory shifts—can precipitate right ventricular dilation and failure.

Immediate lung transplantation was not feasible in this case. Active sepsis, unclear reversibility of organ injury, and profound hemodynamic instability made donor allocation unlikely, while transplanting new lungs into an infected field risked immediate graft failure.

Total Artificial Lung: Design and Physiologic Rationale

To bridge this gap, the surgical team deployed a self-developed total artificial lung system immediately after bilateral lung removal.

According to the report in Med, the TAL system is designed to replicate not only pulmonary gas exchange but also key hemodynamic functions of the native lung. Central to the design is a flow-adaptive shunt connecting the right pulmonary artery to the right atrium, effectively substituting for the pulmonary vascular network and preserving physiologic transcardiac blood flow.

Oxygenated blood is returned to the left heart via two independent conduits, ensuring continuous left ventricular filling and forward aortic valve flow. The configuration reduces cardiac afterload and, importantly, can function without systemic anticoagulation—lowering the risk of bleeding and thrombosis, a limitation of conventional ECMO.

Within hours of TAL initiation, the patient’s hemodynamics improved substantially. Vasopressor requirements decreased rapidly and were discontinued approximately 12 hours after pneumonectomy.

To prevent cardiac displacement within the empty thoracic cavity, surgeons placed saline-filled breast implants—commonly used in reconstructive surgery—as temporary internal supports to stabilize heart position.

Transition to Transplant and Long-Term Outcome

The team reported that following lung removal, the patient’s clinical status improved markedly as the infectious source was eliminated. Despite the absence of systemic anticoagulation, no intracardiac thrombosis was observed, and imaging confirmed favorable flow patterns within the pulmonary vein–left atrium conduits.Approximately 48 hours after pneumonectomy, suitable donor lungs became available. The surgical team proceeded with bilateral lung transplantation. The patient was extubated on postoperative day 7 and discharged eight weeks later.

At more than two years of follow-up, he has resumed normal daily activities. Both ventricles retain normal function, with a left ventricular ejection fraction exceeding 60%, and the transplanted lungs demonstrate sustained functional integrity.

Molecular Insights Into Irreversible ARDS

Beyond its surgical implications, the report also included molecular analyses that may inform ARDS prognosis. Using single-cell and spatial transcriptomic techniques on explanted lung tissue, the researchers identified extensive depletion of reparative cell populations and widespread dominance of profibrotic cell types.

“These findings indicate that in some ARDS patients, the molecular machinery required for lung repair is essentially exhausted,” the authors wrote. In such cases, continued reliance on antimicrobial therapy or ECMO alone may be futile.

The team suggested that similar molecular profiling—potentially via less invasive methods such as bronchoalveolar lavage—could, in the future, help identify patients unlikely to recover native lung function and prompt earlier consideration of transplantation.

Limitations and Implications

The findings are based on a single-patient experience and an institution-specific device, limiting generalizability. Broader validation, regulatory evaluation, and standardized manufacturing would be required before clinical adoption.

Nevertheless, the authors concluded that the case demonstrates a previously unachieved level of physiologic support after total lung removal and highlights a potential new pathway for managing select cases of irreversible lung failure.

0
0
Loading